NASDAQ: ENVB
Enveric Biosciences Inc Stock Forecast, Predictions & Price Target

Analyst price target for ENVB

Based on 1 analyst offering 12 month price targets for Enveric Biosciences Inc

Min Forecast
$10.00+740.34%
Avg Forecast
$10.00+740.34%
Max Forecast
$10.00+740.34%

Should I buy or sell ENVB stock?

Based on 1 analyst offering ratings for Enveric Biosciences Inc.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although ENVB's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates ENVB as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -4.50% per year. Learn More

Be the first to know when Wall Street analysts revise their ENVB stock forecasts and price targets.

ENVB stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-03-06

1 of 1

Forecast return on equity

Is ENVB forecast to generate an efficient return?

Company
-558.6%
Industry
153.19%
Market
81.87%
ENVB's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ENVB forecast to generate an efficient return on assets?

Company
-288.64%
Industry
36.07%
ENVB is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ENVB earnings per share forecast

What is ENVB's earnings per share in the next 1 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$12.90

ENVB vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ENVB$1.19$10.00+740.34%Buy
HEPA$0.27N/AN/A
EYEN$1.07$2.00+86.92%Hold
XRTX$0.87N/AN/A
SNPX$2.05N/AN/A

Enveric Biosciences Stock Forecast FAQ

Is Enveric Biosciences Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: ENVB) stock is to Buy ENVB stock.

Out of 1 analyst, 0 (0%) are recommending ENVB as a Strong Buy, 1 (100%) are recommending ENVB as a Buy, 0 (0%) are recommending ENVB as a Hold, 0 (0%) are recommending ENVB as a Sell, and 0 (0%) are recommending ENVB as a Strong Sell.

If you're new to stock investing, here's how to buy Enveric Biosciences stock.

What is ENVB's earnings growth forecast for 2025-2025?

(NASDAQ: ENVB) Enveric Biosciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 13.28%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.17%.

Enveric Biosciences's earnings in 2025 is -$9,574,987.

In 2025, ENVB is forecast to generate -$31,884,362 in earnings, with the lowest earnings forecast at -$31,884,362 and the highest earnings forecast at -$31,884,362.

What is ENVB's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: ENVB) forecast ROE is -558.6%, which is considered weak.

What is ENVB's Price Target?

According to 1 Wall Street analyst that have issued a 1 year ENVB price target, the average ENVB price target is $10.00, with the highest ENVB stock price forecast at $10.00 and the lowest ENVB stock price forecast at $10.00.

The Wall Street analyst predicted that Enveric Biosciences's share price could reach $10.00 by Mar 6, 2026. The average Enveric Biosciences stock price prediction forecasts a potential upside of 740.34% from the current ENVB share price of $1.19.

What is ENVB's Earnings Per Share (EPS) forecast for 2025-2025?

(NASDAQ: ENVB) Enveric Biosciences's current Earnings Per Share (EPS) is -$19.04. In 2025, ENVB's EPS is forecast to hit -$12.90 (min: -$12.90, max: -$12.90).

What is ENVB's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: ENVB) forecast ROA is -288.64%, which is lower than the forecast US Biotechnology industry average of 36.07%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.